Medication info

Youngjin Intraphusin 10% Injection

Prescription medication
Ingredient · strength
Glycine›10400mgL-Glutamic Acid›10200mgL-Leucine›3800mgL-Isoleucine›2800mgL-Methionine›3600mgL-Tryptophan›1400mgL-Histidine›2300mgL-Proline›9400mgL-Serine›9400mgL-Phenylalanine›2700mgL-Alanine›17300mgL-Arginine›9300mgL-Threonine›3600mgL-Valine›3100mgAcetylcysteine›700mgN-Acetyl-L-Tyrosine›1500mgL-Glutamic Acid·L-Lysine Salt (1:1) Dihydrate›10100mg
Manufacturer / importer
Youngjin Pharmaceutical Co., Ltd.
Appearance
A colorless-yellowish solution in a colorless transparent glass bottle sealed with a rubber stopper for infusion.
Packaging
250 mL/bottle, 500 mL/bottle
Approval status
Active

MFDS item code 198700578 · Notified 1987.09.01

Summary

Main use
Nutritional improvement through amino acid supplementation (e.g., for hypoproteinemia and malnutrition)
Who uses it
Adults · Children
Adult dosage
○ Adults: Administer by intravenous infusion a maximum daily dose of 1~1.5 g of total amino acids per kg of body weight. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is desirable; in principle, infuse at a rate of 30~40 drops per minute.
Children's dosage
For children, older adults, and patients with burns who have high protein requirements, adjust the dose and infusion rate appropriately before administration.

Ingredients

Manufacturer
Youngjin Pharmaceutical Co., Ltd.

Efficacy & effects

Nutritional improvement through amino acid supplementation (e.g., for hypoproteinemia and malnutrition)

  • Hypoproteinemia
  • malnutrition
View approved original text

Hypoproteinemia, malnutrition, and supplying amino acids before and after surgery helps enhance protein synthesis in the body, improves nutritional status, and promotes recovery.

Dosage and Administration

Adult dosage

○ Adults: Administer by intravenous infusion a maximum daily dose of 1~1.5 g of total amino acids per kg of body weight. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is desirable; in principle, infuse at a rate of 30~40 drops per minute.

Children's dosage

For children, older adults, and patients with burns who have high protein requirements, adjust the dose and infusion rate appropriately before administration.

Precautions

This medication must be used according to a doctor's instructions. It should not be used in patients with hepatic coma or at risk of hepatic coma, severe renal impairment, hypernitrogenemia, metabolic disorders with nitrogen utilization issues, heart failure, or pulmonary edema. Do not administer to patients with low or absent urinary output, acidosis, excess body fluid, hypokalemia, or those in shock. It should be used with caution in patients with congestive heart failure or impaired liver and kidney function, as side effects such as skin rash, nausea, vomiting, chest discomfort, palpitations, and increased blood pressure may occur. Rapid large doses can cause acidosis, and rarely symptoms such as chills, fever, headache, dyspnea, and shock may occur. Metabolic complications may include acidosis, hypophosphatemia, alkalosis, hyperglycemia, diabetes, dehydration, hypoglycemia, elevated liver enzymes, vitamin imbalance, electrolyte abnormalities, and childhood hyperammonemia. Patients with impaired liver or kidney function may have elevated levels of blood urea nitrogen (BUN), and patients with liver failure may demonstrate severe symptoms such as serum amino acid imbalance or coma. Beware of electrolyte balance when administering large doses or using it with electrolyte solutions, as excessive administration can lead to metabolic alkalosis. In patients with a history of kidney disease, lung disease, or heart disease, it must be administered carefully while avoiding excessive fluid supply. Diabetic patients should frequently monitor their blood glucose levels. This medication may reduce the protein-sparing effect when used with specific antibiotics such as tetracycline. The safety for pregnant women has not been established, and it should only be used when the benefit outweighs the risk. In children, due to immature liver function, hyperammonemia can occur, so the concentration should be kept low and blood ammonia levels should be monitored frequently. In the elderly, given the decreased physical function, the administration rate should be slow and the dosage adjusted. This medication should be administered slowly intravenously, as rapid injection can cause chills or vomiting. Before use, adjust the temperature to body temperature, and ensure aseptic conditions for preparation and management. Do not use if the solution is cloudy or discolored, and it should be stored in the refrigerator for no more than 24 hours. If crystals form, dissolve by heating and cool to body temperature before use. Care must be taken to prevent discoloration until the packaging is opened, and it should not be used if the container or stopper is damaged. It is safer for patients with a history of myocardial infarction not to use this medication.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • rapid heartbeat
  • increased blood pressure
  • acidosis
  • chills
  • fever
Show 26 more
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchospasm
  • utero contraction
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • increased BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogenemia
  • hyperammonemia
  • sensory loss
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture ingress, preferably at room temperature. This will help maintain the drug's efficacy and prevent degradation.

Appearance and packaging

Appearance

A colorless-yellowish solution in a colorless transparent glass bottle sealed with a rubber stopper for infusion.

Package unit

250 mL/bottle, 500 mL/bottle

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.